Dragon Pharma Vesilute 20 mg – Peptide Bioregulator for Bladder Research
✔ Research-grade peptide complex ✔ Lyophilized powder format ✔ Bladder-focused bioregulator ✔ Sterile 2 mL vial presentation
Dragon Pharma Vesilute 20 mg is a research-use peptide bioregulator developed for scientific investigation of bladder and lower urinary tract tissues. Vesilute is positioned within a broader class of tissue-specific peptide complexes studied for their potential role in supporting cellular communication, tissue maintenance, and regenerative signaling in target organs.
Supplied as a lyophilized powder in a sterile 2 mL vial, this formulation is intended for controlled laboratory protocols where researchers are examining mechanisms related to urothelial repair, inflammatory response, epithelial integrity, and age-associated tissue changes. Interest in bladder-specific peptide bioregulators has grown in regenerative science because of their potential relevance to cellular homeostasis and tissue recovery pathways.
Each vial of Vesilute 20 mg by Dragon Pharma contains a carefully prepared peptide complex suitable for structured research settings. Experimental work involving related organ-specific peptides has explored how short peptide fractions may influence gene expression, protein synthesis, and tissue-specific functional regulation. Researchers interested in the wider regenerative context may review this overview of peptides in tissue repair.
Potential Research Applications
Under laboratory conditions, Dragon Pharma Vesilute is primarily investigated for its possible cytomodulating, tissue-supportive, and anti-inflammatory effects within bladder structures. Current scientific interest centers on how peptide bioregulators may contribute to the restoration of epithelial integrity and normalization of tissue function in the urinary system.
Areas commonly explored in Vesilute-related research include:
- Urothelial regeneration and epithelial repair
- Bladder inflammation and cytokine signaling
- Lower urinary tract tissue maintenance
- Age-related bladder function research
- Cellular signaling in urinary tissue recovery models
- ✔ Designed for bladder-focused peptide research
- ✔ Commonly examined in tissue-regeneration models
- ✔ Lyophilized format supports stability before reconstitution
- ✔ Suitable for controlled laboratory investigation
- ✔ Relevant to urinary tissue signaling research
Lab Report Update
Third-party analytical report for Vesilute 20 mg is not yet available. Batch-specific testing visuals and assay details will be added here once released.
Technical Details
Peptide Type
Synthetic Linear Dipeptide
Peptide Sequence
Glu-Asp (ED)
Peptide Length
2 Amino-Acid Residues
Terminal Form
H-Glu-Asp-OH
Molecular Formula
C₉H₁₄N₂O₇
Molecular Weight
262.22 g/mol
Research Status
Experimental
Handling & Research Guidelines
Research use only. Vesilute 20 mg is supplied as a lyophilized peptide and requires reconstitution with bacteriostatic water prior to experimental handling.
Peptide Handling Profile
- ✔ Lyophilized peptide requiring reconstitution
- ✔ Typically prepared under sterile laboratory conditions
- ✔ Stability depends on proper storage and handling
After reconstitution, peptide solutions should be handled using standard sterile laboratory practices. Proper storage, accurate measurement, and contamination control are critical to maintaining peptide integrity during experimental use.
Research Dosage Context
In laboratory settings, Vesilute 20 mg is commonly evaluated within controlled experimental ranges. Research protocols involving tissue-specific peptides often explore dosing parameters between 5 mg and 20 mg depending on study design and biological model.
Because Vesilute is a bladder-targeted peptide bioregulator, dosing strategies are typically adjusted based on the intended research objective, whether focused on tissue regeneration, inflammatory signaling, or cellular response analysis.
Research Protocol Structures
Experimental protocols involving Dragon Pharma Vesilute often aim to observe cumulative effects over time. Structured research programs may include repeated administrations across several weeks to evaluate both short-term cellular responses and longer-term tissue adaptation.
Vesilute may be investigated as a standalone compound or as part of broader regenerative research models. For example, studies examining systemic tissue repair pathways may combine peptide bioregulators with compounds such as TB-500. In research exploring urinary function and hormonal influence, compounds like Finasteride may be used for comparative analysis.
Observed Research Considerations
Available data on tissue-specific peptide complexes suggests generally stable behavior under controlled experimental conditions. Observations reported in laboratory environments are typically related to handling variables rather than compound instability.
- Peptide stability depends on proper reconstitution and storage
- Degradation risk increases with repeated temperature fluctuation
- Strict sterile technique reduces contamination variables
Future Research Potential
Interest in bladder-specific peptide bioregulators continues to expand as research explores new approaches to urothelial repair, inflammation control, and tissue signaling. Early-stage studies suggest that peptides like Vesilute may influence pathways related to cellular communication and structural integrity within urinary tissues.
Ongoing experimental work is evaluating how Vesilute may function alongside other regenerative compounds to better understand mechanisms involved in lower urinary tract function. By providing a high-purity peptide reference material, Dragon Pharma Vesilute 20 mg supports structured investigation in modern peptide research environments.
Note: This product is intended strictly for research purposes. Protocol design, dosing, and handling should be determined by qualified professionals within controlled laboratory settings.
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 hours after payment confirmation
Tracking
Tracking number provided after shipment
Direct Manufacturer Supply
This product is supplied through the official Dragon Pharma distribution chain and delivered in original sealed manufacturer packaging. Orders are shipped using discreet outer packaging with no unnecessary product identification.
Lyophilized peptide products are packaged for standard transit conditions prior to reconstitution and storage.
What to Expect
- ✔ Orders are processed after payment confirmation
- ✔ USA Domestic warehouse offers faster delivery when selected
- ✔ International shipping includes tracking (updates may vary by region)
- ✔ Multiple warehouses may result in split shipments if applicable
- ✔ Reshipment support available in case of delivery issues
Authenticity support: official Dragon Pharma presentation, original manufacturer packaging, and controlled distribution sourcing help reinforce product legitimacy and buyer confidence.
Verified Supply
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Before Reconstitution
Store at controlled room temperature (15–25°C) in a dry place, protected from direct light and excessive heat. Keep vials in their original packaging to preserve the stability of the lyophilized peptide.
After Reconstitution
Once reconstituted with bacteriostatic water, store the solution refrigerated at 2–8°C. Do not freeze. Avoid shaking the vial; gently swirl if needed.
Inspect the solution before use in research settings. Do not use if it appears cloudy, discolored, or contains visible particles.
Reconstituted peptide solutions are typically used within a limited timeframe under controlled conditions to maintain stability and integrity.
Keep out of reach of children. Follow proper sterile handling practices during preparation and laboratory use.
Proper storage conditions help preserve peptide stability and structural integrity throughout its usable period.
Tip: Avoid repeated temperature changes after reconstitution, as this may accelerate peptide degradation.
Frequently Asked Questions
What is Vesilute?
Vesilute is a synthetic peptide bioregulator derived from bladder tissue. It is studied for its potential role in supporting cellular signaling, inflammation control, and urothelial regeneration.
What makes Dragon Pharma Vesilute different from standard medications?
Unlike conventional medications that mainly block receptors to relieve symptoms, Vesilute is investigated for its potential ability to influence cellular repair processes within bladder tissues.
How should Vesilute 20 mg be stored?
The lyophilized powder should be stored in a cool, dry place away from direct light. Refrigeration at 2–8°C is recommended. Once reconstituted, the solution should remain refrigerated.
Can Vesilute be studied for male urinary health?
Yes. Research involving bladder peptides has explored their potential role in studies related to lower urinary tract symptoms associated with prostate enlargement and urinary dysfunction.
Does Vesilute affect hormones?
No. Vesilute is a peptide bioregulator and does not interact with androgen or estrogen receptors. It does not influence testosterone or estrogen levels.
No reviews found
Please log in to write Vesilute 20 mg review.
